Dr. Mirza awarded a 51ÁÔÆæ Discovery and Innovation Grant (DIG)
Professor Shama Mirza received 51ÁÔÆæ funds to predict responses to anti-VEGF therapy in recurrent glioblastoma Glioblastoma (GBM) is the most aggressive of all brain tumors with limited treatment options and no cure. Even after multimodal treatments by surgical resection of …